15 / 18
14
Diretrizes AMB
5.
Lin KC, Huang YH, Hsieh YW, Wu CY. Potential predictors of motor and functional outcomes
after distributed constraint-induced therapy for patients with stroke. Neurorehabil Neural Repair
2009; 23: 336-42. PMID: 18984830.
6.
Smits DW, Gorter JW, Ketelaar M, Van Schie PE, Dallmeijer AJ, Lindeman E, et al. Relationship
between gross motor capacity and daily-life mobility in children with cerebral palsy. Dev Med
Child Neurol 2010; 52: e60-6. PMID: 20002126.
7.
Whiting J, Rutjes AW, Dinnes J, Reitsma JB, Bossuyt PM, Kleijnen J. Development and validation
of methods for assessing the quality of diagnostic accuracy studies. Health Tech Assess 2004; 8
(25).
8.
Consort de publicação de Ensaios Clínicos Randomizados: Disponível em
http://www.consort- statement.org/consort-statement/ .9.
Nível de Evidência Científica por Tipo de Estudo – “Oxford Centre for Evidence-based Medicine”
2009. Disponível e
m www.cebm.net10.
Bottos M, Benedetti MG, Salucci P, Gasparroni V, Giannini S. Botulinum toxin with and without
casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med
Child Neurol 2003; 45:758-62. PMID: 14580131.